Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Carcinoma, Transitional Cell × Injections × 90 days × Clear all

Sponsor

Conditions

Leukemia, Myeloid, Acute 19 Myelodysplastic Syndromes 8 Leukemia, Myelomonocytic, Chronic 7 Carcinoma, Non-Small-Cell Lung 7 Advanced Solid Tumor 6 Solid Tumor 4 Neoplasms 4 Myeloproliferative Disorders 4 Advanced Solid Tumour 4 Advanced Solid Tumors 4 Breast Neoplasms 3 Triple Negative Breast Neoplasms 2 Sarcoma 2 Recurrence 2 Precursor Cell Lymphoblastic Leukemia-Lymphoma 2 Ovarian Neoplasms 2 Myelodysplastic-Myeloproliferative Diseases 2 Multiple Myeloma 2 Lymphoma, Large B-Cell, Diffuse 2 Lymphoma 2 Lung Neoplasms 2 Leukemia, Monocytic, Acute 2 Fallopian Tube Neoplasms 2 Colorectal Neoplasms 2 Carcinoma, Hepatocellular 2 Biliary Tract Neoplasms 2 Uterine Cervical Neoplasms 1 Tuberous Sclerosis 1 Thrombocythemia, Essential 1 Strabismus 1

Interventions

pembrolizumab 20 enfortumab vedotin 12 Magnetic Resonance Spectroscopy 9 avelumab 8 Specimen Handling 8 Nivolumab 8 Gemcitabine 7 Cisplatin 7 atezolizumab 6 Carboplatin 6 sacituzumab govitecan 4 Ipilimumab 4 Docetaxel 4 durvalumab 3 lenvatinib 2 dodecyl maltoside 2 cabozantinib 2 Paclitaxel 2 Mitomycin 2 Immunoglobulin G 2 Fluorodeoxyglucose F18 2 CTLA-4 Antigen 2 Biopsy 2 ALT-803 2 zimberelimab 1 zanidatamab 1 toripalimab 1 tocilizumab 1 tislelizumab 1 tazemetostat 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡